Abstract: Cultures of cells immunoreactive for glial fibrillary acidic protein (GFAP), as well as for the intermediate filament marker nestin were grown in a medium including epidermal growth factor (EGF) and serum. The cultured cells had the morphology of astroglial cells. The cells can be proliferated in adherent or suspension cultures. Depending on the culture conditions, the cells can be induced to differentiate to neurons or glial cells. The cultures can be expanded over a large number of passages during several months, and survive, express an astroglial phenotype and integrate well after transplantation into both neonatal and adult rat forebrain.
Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagents that bind to cell surface markers are provided.
Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
Type:
Grant
Filed:
July 11, 2002
Date of Patent:
May 15, 2007
Assignee:
StemCells California, Inc.
Inventors:
David W. Buck, Nobuko Uchida, Irving Weissman
Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
Type:
Grant
Filed:
August 9, 2001
Date of Patent:
December 26, 2006
Assignee:
Stemcells California, Inc.
Inventors:
Nobuko Uchida, David W. Buck, Irving Weissman
Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
Type:
Grant
Filed:
February 23, 2001
Date of Patent:
September 12, 2006
Assignee:
StemCells California, Inc.
Inventors:
David W. Buck, Nobuko Uchida, Irving Weissman
Abstract: The invention provides a method for using collagenase to dissociate neural stem cells in neural stem cell cultures. The collagenase treatment results in an increased cell viability and an increased number of proliferated neural stem cells over time.
Abstract: Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
Type:
Grant
Filed:
February 11, 2000
Date of Patent:
May 2, 2006
Assignee:
StemCells California, Inc.
Inventors:
David W. Buck, Nobuko Uchida, Irving Weissman
Abstract: The invention provides a method for determining the effect of a biological agent comprising contacting a cell culture with a biological agent. The cell culture of the invention contains a culture medium containing one or more preselected growth factors effective for inducing multipotent central nervous system (CNS) neural stem cell proliferation. The cell culture also contains, suspended in the culture medium, human multipotent CNS neural stem cells that are derived from primary CNS neural tissue that have a doubling rate faster than 30 days.